CAMBRIDGE, Mass., May 5, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided a research and development (R&D) update and announced financial results for the first quarter of 2008.
